Perspective Therapeutics (CATX) Long-Term Investments (2014 - 2016)

Perspective Therapeutics has disclosed Long-Term Investments across 3 years of filings, most recently posting $3.0 million for Q2 2016.

• Long-Term Investments for Q2 2016 came in at $3.0 million, down 41.78% year-over-year; the trailing twelve-month figure through Jun 2016 was $3.0 million (down 41.78% YoY), and the FY2016 annual result was $3.0 million, down 41.78% from the prior year.
• Long-Term Investments came in at $3.0 million for Q2 2016 at Perspective Therapeutics, down from $5.2 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $5.4 million in Q2 2014 to a low of $3.0 million in Q2 2016.
• The 3-year median for Long-Term Investments is $5.2 million (2015), against an average of $4.8 million.
• Across the five-year window, Long-Term Investments dropped 5.45% in 2015 and sank 41.78% in 2016, its largest moves.
• Perspective Therapeutics' Long-Term Investments stood at $5.4 million in 2014, then declined by 4.4% to $5.2 million in 2015, then slumped by 42.42% to $3.0 million in 2016.
• The last three Long-Term Investments figures came in at $3.0 million (Q2 2016), $5.2 million (Q1 2016), and $5.2 million (Q4 2015), per Business Quant data.